Search results
Skin rash
- Morbilliform drug reactions, a term derived from "morbilli," which means measles, describe a particular type of skin rash that can develop as an adverse reaction to certain medications. These rashes often resemble the rash associated with measles, with characteristic red spots that may be itchy and can spread across the body.
People also ask
What is a morbilliform drug eruption?
What are the symptoms of a morbilliform drug eruption?
What are the immunological mechanisms for morbilliform drug eruptions?
May 23, 2024 · The term describes a usually faint and mild cutaneous eruption that exhibits the combined characteristics of macules (discolored areas of skin that are not elevated above the surface) and papules (small, solid, usually inflammatory elevations of the skin that do not contain pus), and the rash is often referred to as morbilliform (in resembling ...
May 15, 2024 · May 15, 2024. Editors' notes. Exploring the mechanism behind drug eruptions in the skin. by Chiba University. Using genetically engineered mice expressing a specific variant of HLA, researchers...
May 5, 2024 · Exanthems (erythematous, morbilliform or maculopapular), urticaria, fixed drug eruptions, and erythema multiforme are the most common. Figure 18-1 is an urticarial reaction from Augmentin and Fig. 18-2 shows a morbilliform eruption from ampicillin.
May 17, 2024 · Cutaneous eruptions associated with DRESS exhibit a diverse range of presentations; however, the morbilliform eruption is the most common presentation. This characteristic rash is typically diffuse, macular and exanthema, progressing to edematous state with follicular accentuation.
May 15, 2024 · Using genetically engineered mice expressing a specific variant of HLA, researchers uncover the instrumental role of this protein in the development of drug eruptions. They...
6 days ago · Morbilliform drug eruption. Morbilliform drug eruptions are type IV immune-mediated reactions mediated by cytotoxic T cells . At least two cases in the literature have been reported of dulaglutide-related morbilliform drug eruptions [31, 32]. In one case, 2 weeks following replacement of repaglinide with dulaglutide in a 75-year-old male ...
